• 1
    Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 1976; 260: 808809.
  • 2
    Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA–array technology. Arthritis Rheum 2001; 44: 27772789.
  • 3
    Nguyen Q, Mort JS, Roughley PJ. Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 1992; 89: 11891197.
  • 4
    Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761768.
  • 5
    Reboul P, Pelletier JP, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996; 97: 20112019.
  • 6
    Fosang AJ, Last K, Gardiner P, Jackson DC, Brown L. Development of a cleavage site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem J 1995; 310: 337343.
  • 7
    Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinase, and cathepsin B. J Biol Chem 1992; 267: 1947019474.
  • 8
    Lark MW, Bayne EK, Flanagan J, Harper CF, Horner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage. J Clin Invest 1997; 100: 93106.
  • 9
    Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne A, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenase in osteoarthritic articular cartilage. J Clin Invest 1997; 99: 15341545.
  • 10
    Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan: evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 1992; 267: 10081014.
  • 11
    Fosang AJ, Last K, Maciewicz RA. Aggrecan is degraded by matrix metalloproteinases in human arthritis. J Clin Invest 1996; 98: 22922299.
  • 12
    Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA. Cleavage of cartilage proteoglycans between G1 and G2 domains by stromelysin. J Biol Chem 1991; 266: 1557915582.
  • 13
    Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu373-Ala374 bond of the interglobular domain. J Clin Invest 1992; 89: 15121516.
  • 14
    Lark MW, Gordy JT, Weidner JR, Ayala J, Kimura JH, Williams HR, et al. Cell-mediated catabolism of aggrecan: evidence that cleavage at the “aggrecanase” site [Glu373-Ala374] is a primary event in proteolysis of the interglobular domain. J Biol Chem 1995; 270: 25502556.
  • 15
    Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 1993; 36: 12141222.
  • 16
    Sandy JD, Verscharen C. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J 2001; 358: 615626.
  • 17
    Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999; 284: 16641666.
  • 18
    Tortorella MD, Pratta M, Liu RQ, Austin J, Ross OH, Abbaszade I, et al. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS- 4). J Biol Chem 2000; 275: 1856618573.
  • 19
    Arner EC, Pratta MA, Tzaskos JM, Decicco CP, Tortorella MD. Generation and characterization of aggrecanase. J Biol Chem 1999; 274: 65946601.
  • 20
    Büttner FH, Hughes CE, Margerie D, Lichte A, Tschesche H, Caterson B, et al. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites: characterization of MT1-MMP catabolic activities by the interglobular domain of aggrecan. Biochem J 1998; 333: 159165.
  • 21
    Kuno K, Okada Y, Kawashima H, Nakamura H, Miyasaka M, Ohno H, et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000; 478: 241245.
  • 22
    Büttner FH, Chubinskaya S, Margerie D, Huch K, Flechtenmacher J, Cole AA, et al. Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum 1997; 40: 704709.
  • 23
    Flannery CR, Little CB, Caterson B, Hughes CE. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. Matrix Biol 1999; 18: 225237.
  • 24
    McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13: 534540.
  • 25
    McKenna LA, Gehrsitz A, Soder S, Eger W, Kirchner T, Aigner T. Effective isolation of high quality total RNA from human adult articular cartilage. Anal Biochem 2000; 286: 8085.
  • 26
    Häuselmann HJ, Aydelotte MB, Schumacher BL, Kuettner KE, Gitelis SH, Thonar EJ. Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix 1992; 12: 116119.
  • 27
    Gehrsitz A, McKenna LA, Soder S, Kirchner T, Aigner T. Isolation of RNA from small human articular cartilage specimens allows quantification of mRNA expression levels in local articular cartilage defects. J Orthop Res 2001; 19: 478482.
  • 28
    Mengshol JA, Mix KS, Brinckerhoff CE. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull′s-eye or missing the mark? Arthritis Rheum 2002; 46: 1320.
  • 29
    Chubinskaya S, Kuettner KE, Cole AA. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints. Lab Invest 1999; 79: 16691677.
  • 30
    Zafarullah M, Martel-Pelletier J, Cloutier J-M, Gedamu L, Pelletier JP. Expression of c-fos, c-jun, jun-B, metallothionin and metalloproteinase genes in human chondrocyte. FEBS Lett 1992; 306: 169172.
  • 31
    Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC, et al. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 2002; 168: 14051412.
  • 32
    Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA–DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991; 34: 10941105.
  • 33
    Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner FJ Jr. Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 1983; 26: 6368.
  • 34
    Ehrlich MG, Houle PA, Vigliani G, Mankin HJ. Correlation between articular cartilage collagenase activity and osteoarthritis. Arthritis Rheum 1978; 21: 761766.
  • 35
    Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg 1971; 53-A: 523537.
  • 36
    Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum 2000; 43: 664672.
  • 37
    Hambach L, Neureiter D, Zeiler G, Kirchner T, Aigner T. Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum 1998; 41: 986997.
  • 38
    Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997; 151: 245256.
  • 39
    Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 24462451.
  • 40
    Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996; 393: 101104.
  • 41
    Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 15441550.
  • 42
    Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 1712417131.
  • 43
    Häuselmann HJ, Fernandes RJ, Mok SS, Schmid TM, Block JA, Aydelotte MB, et al. Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci 1994; 107: 1727.
  • 44
    Bonaventure J, Khadom N, Cohen-Solal L, Ng KH, Bourguignon J, Lasselin C, et al. Re-expression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res 1994; 212: 97104.
  • 45
    Flannery CR, Little CB, Hughes CE, Caterson B. Expression of ADAMTS homologues in articular cartilage. Biochem Biophys Res Commun 1999; 260: 318322.
  • 46
    Kandel RA, Petelycky M, Dinarello CA, Minden M, Pritzker KPH, Cruz TF. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes. J Rheumatol 1990; 17: 953957.
  • 47
    Stephenson ML, Goldring MB, Birkhead JR, Krane M, Rahmsdorf HJ, Angel P. Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1 beta or phorbol ester. Biochem Biophys Res Commun 1987; 144: 583590.
  • 48
    Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000; 43: 801811.
  • 49
    Tortorella MD, Malfait A, Deccico C, Arner E, Nagase H. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001; 9: 539552.
  • 50
    Bluteau G, Conrozier T, Mathieu P, Vignon E, Herbage D, Mallein-Gerin F. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 2001; 1526: 147158.
  • 51
    Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, et al. Susceptibility of stromelysin 1–deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998; 41: 110121.
  • 52
    Cawston T, Billington C, Cleaver C, Elliott S, Hui W, Koshy P, et al. The regulation of MMPs and TIMPs in cartilage turnover. Ann N Y Acad Sci 1999; 878: 120129.
  • 53
    Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, et al. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999; 42: 129136.
  • 54
    Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997; 40: 20652074.